Project Grant R01HG014564
Award Date 9/25/25
Completion Date 7/31/30
Dollars Obligated $878K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $716,587 to Boston Children's Hospital to advance equity in rare disease genomic research. The key objectives are to: Develop and implement a Diversity, Equity, and Inclusion toolkit within the Broad Institute's Rare Genomes Project to improve engagement and participation from historically underrepresented populations in rare disease genomic studies. This will involve...
- This federal Project Grant award of $308,799, provided by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), supports research to integrate 4DN data with transcriptome data from the Undiagnosed Disease Network (UDN) and Genotype-Tissue Expression (GTEx) Project. The goal is to leverage 3D genomic information to identify functional rare genetic variants that contribute to rare diseases. The Leland Stanford Junior University, a leading research...
- This federal Project Grant award of $423,750.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant, awarded on May 1, 2025, supports a research project at New York University (NYU) School of Medicine to develop new conceptual and statistical approaches that integrate molecular, cellular, and population genetics to better understand the genetic basis of complex human traits and diseases....
- This federal Cooperative Agreement award from the National Human Genome Research Institute (NHGRI) under the "Human Genome Research" program (CFDA 93.172) provides $666,227 to Meharry Medical College to establish a Diversity Center for Genome Research (DCGR). The goal of the DCGR is to narrow inequitable representation gaps for underrepresented minority (URM) groups in genomics research by building infrastructure, forming interdisciplinary research teams, and promoting community...
- This federal Project Grant award, provided by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research), supports the development of innovative computational and statistical methods for conducting genome-wide association studies (GWAS) on time-to-event (TTE) phenotypes in large biobanks and cohorts. The $3,287,168 award, granted on September 17, 2025, aims to overcome current limitations in GWAS of TTE phenotypes by developing scalable methods for rare variant...
- This federal Project Grant award of $245,753.00 by the National Science Foundation's Social, Behavioral, and Economic Sciences program (CFDA 47.075) supports research into the translation of scientific research, specifically human genomic analysis, into a medical tool for newborn genomic screening. The project investigates the scientific research, biotechnology actors, and other interested parties driving this development, as well as its effects on patients, healthcare systems, and society....
- This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) is focused on developing and applying machine learning-based approaches to estimate disease risk in diverse and admixed populations. The $399,156 award to Galatea Bio Inc., a minority-owned small disadvantaged business located in Miami Lakes, FL, will support the following key objectives over the project period from September 2024 to August 2025: Evaluating the performance of existing...
- The federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,507,500 to the University of Massachusetts Medical School (UMass Medical) to expand the capabilities of third-generation DNA/RNA sequencing technologies. The project aims to generate rapid and cost-effective training libraries to allow for direct detection of common DNA damage and RNA modifications, enabling innovative...
- The National Human Genome Research Institute (NHGRI) awarded a $1,711,422 Project Grant (CFDA 93.172 - Human Genome Research) to the New York Genome Center, Inc. (NYGC) on September 23, 2024. The goal of this project is to develop a suite of privacy-preserving tools for transcriptomic data analysis, including methods for quantifying bulk and single-cell gene expression, as well as performing expression quantitative trait locus (eQTL) mapping on encrypted genotypes. This will enable large-scale...
- This $993,446 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 Human Genome Research) supports the development of statistical and machine learning approaches to decode the regulatory activity underlying disease variants, link variants to genes in relevant cell types, and identify disease-critical cooperative programs of genes and genomic elements. The goal is to produce computational tools and workflows that can identify and rank functionally disease-critical...